{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:45:17Z","timestamp":1794336317817,"version":"4.9.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jaccao.2025.01.018","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:26:22Z","timestamp":1741782382000},"page":"268-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical Phenotype and Prognostic Significance of Frailty in\u00a0Transthyretin Cardiac Amyloidosis"],"prefix":"10.1016","volume":"7","author":[{"given":"Carlo","family":"Fumagalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5017-8657","authenticated-orcid":false,"given":"Adam","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuf","family":"Razvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3307-0825","authenticated-orcid":false,"given":"Aldostefano","family":"Porcari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Zampieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Perfetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad U.","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Martinez-Naharro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Venneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviva","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Wechalekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3960-9270","authenticated-orcid":false,"given":"Raffaele","family":"Marfella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ungar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Marchionni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian D.","family":"Gillmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5074-2078","authenticated-orcid":false,"given":"Marianna","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2025.01.018_bib1","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.122.060852","article-title":"Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years","volume":"146","author":"Ioannou","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2025.01.018_bib2","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/ejhf.2646","article-title":"Sex differences among patients with transthyretin amyloid cardiomyopathy \u2013 from diagnosis to prognosis","volume":"24","author":"Patel","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2025.01.018_bib3","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.mayocp.2021.04.021","article-title":"Early diagnosis and outcome in patients with wild-type transthyretin cardiac amyloidosis","volume":"96","author":"Fumagalli","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaccao.2025.01.018_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2025.01.018_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jchf.2023.08.032","article-title":"Tafamidis efficacy among octogenarian patients in the phase 3 ATTR-ACT and ongoing long-term extension study","volume":"12","author":"Garcia-Pavia","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jaccao.2025.01.018_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101123","article-title":"Comprehensive geriatric assessment to optimize the management of older patients with transthyretin cardiac amyloidosis","volume":"3","author":"Fumagalli","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.jaccao.2025.01.018_bib7","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","article-title":"Frailty: implications for clinical practice and public health","volume":"394","author":"Hoogendijk","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2025.01.018_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ageing\/afaa219","article-title":"Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies","volume":"50","author":"O\u2019Caoimh","year":"2021","journal-title":"Age Ageing"},{"key":"10.1016\/j.jaccao.2025.01.018_bib9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2025.01.018_bib10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jchf.2019.10.005","article-title":"Frailty is intertwined with heart failure","volume":"7","author":"Ambarish","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jaccao.2025.01.018_bib11","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2468-2667(18)30091-4","article-title":"Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants","volume":"3","author":"Hanlon","year":"2018","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jaccao.2025.01.018_bib12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/ejhf.1611","article-title":"Heart\u00a0Failure Association of the European Society of Cardiology position paper on frailty in patients with heart failure","volume":"21","author":"Vitale","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2025.01.018_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurjpc\/zwaa167","volume":"29","author":"Richter","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jaccao.2025.01.018_bib14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ejhf.2198","article-title":"Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2025.01.018_bib15","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A\u00a0new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2025.01.018_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A\u00a0global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jaccao.2025.01.018_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12877-020-01801-7","article-title":"A\u00a0scoping review of the Clinical Frailty Scale","volume":"20","author":"Church","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jaccao.2025.01.018_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5770\/cgj.23.463","article-title":"Using the Clinical Frailty Scale in allocating scarce health care resources","volume":"23","author":"Rockwood","year":"2020","journal-title":"Can Geriatr J"},{"key":"10.1016\/j.jaccao.2025.01.018_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1536867X1001000303","article-title":"Comparing the predictive powers of survival models using Harrell\u2019s C or Somers\u2019 D","volume":"10","author":"Newson","year":"2010","journal-title":"Stata J"},{"key":"10.1016\/j.jaccao.2025.01.018_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4330\/wjc.v13.i1.1","article-title":"Frailty, sarcopenia and cachexia in heart failure patients: Different clinical entities of the same painting","volume":"13","author":"Beltrami","year":"2021","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jaccao.2025.01.018_bib21","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/jcsm.13306","article-title":"Frailty and heart failure: State-of-the-art review","volume":"14","author":"Talha","year":"2023","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jaccao.2025.01.018_bib22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jacc.2023.05.038","article-title":"Impact of geroscience on therapeutic strategies for older adults with cardiovascular disease","volume":"82","author":"Forman","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2025.01.018_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2021.02.062","article-title":"Gender differences in the prevalence of frailty in heart failure: a systematic review and meta-analysis","volume":"333","author":"Davis","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaccao.2025.01.018_bib24","article-title":"Multiorgan dysfunction and associated prognosis in transthyretin cardiac amyloidosis","volume":"13","author":"Ioannou","year":"2024","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2025.01.018_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2025.01.018_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ejhf.2776","article-title":"Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy","volume":"25","author":"Porcari","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2025.01.018_bib27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2013.09.070","article-title":"Frailty assessment in the cardiovascular care of older adults","volume":"63","author":"Afilalo","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2025.01.018_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40520-024-02750-6","article-title":"Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study","volume":"36","author":"Fumagalli","year":"2024","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jaccao.2025.01.018_bib29","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s40520-023-02419-6","article-title":"Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis","volume":"35","author":"Fumagalli","year":"2023","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jaccao.2025.01.018_bib30","first-page":"3415","article-title":"Frailty in wild-type transthyretin cardiac amyloidosis: the tip of the iceberg","volume":"10","author":"Broussier","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jaccao.2025.01.018_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008105","article-title":"Prevalence and prognostic significance of frailty among patients with transthyretin amyloidosis cardiomyopathy","volume":"14","author":"Fine","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jaccao.2025.01.018_bib32","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1016\/S2666-7568(23)00208-8","article-title":"Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults","volume":"4","author":"Denkinger","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.jaccao.2025.01.018_bib33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2025.01.018_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2023.09.013","article-title":"Assessing and managing frailty in advanced heart failure: an International Society for Heart and Lung Transplantation consensus statement","volume":"43","author":"Denfeld","year":"2024","journal-title":"The J Heart Lung Transplant"},{"key":"10.1016\/j.jaccao.2025.01.018_bib35","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2019.03.467","article-title":"Deprescribing in older adults with cardiovascular disease","volume":"73","author":"Krishnaswami","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2025.01.018_bib36","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/CIRCULATIONAHA.116.025958","article-title":"The Clinical Frailty Scale","volume":"135","author":"Afilalo","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2025.01.018_bib37","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087325000857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087325000857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T11:32:45Z","timestamp":1746271965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087325000857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2666087325000857"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2025.01.018","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Phenotype and Prognostic Significance of Frailty in\u00a0Transthyretin Cardiac Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2025.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}